Your browser doesn't support javascript.
loading
BVVL/ FL: features caused by SLC52A3 mutations; WDFY4 and TNFSF13B may be novel causative genes.
Khani, Marzieh; Shamshiri, Hosein; Taheri, Hanieh; Hardy, John; Bras, Jose Tomas; Carmona, Susana; Moazzeni, Hamidreza; Alavi, Afagh; Heshmati, Ali; Taghizadeh, Peyman; Nilipour, Yalda; Ghazanfari, Tooba; Shahabi, Majid; Okhovat, Ali Asghar; Rohani, Mohammad; Valle, Giorgio; Boostani, Reza; Abdi, Siamak; Eshghi, Shaghayegh; Nafissi, Shahriar; Elahi, Elahe.
Afiliação
  • Khani M; School of Biology, College of Science, University of Tehran, Tehran, Iran.
  • Shamshiri H; Department of Neurology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Taheri H; School of Biology, College of Science, University of Tehran, Tehran, Iran.
  • Hardy J; Department of Molecular Neuroscience, Institute of Neurology, University College London, London, UK.
  • Bras JT; Department of Molecular Neuroscience, Institute of Neurology, University College London, London, UK.
  • Carmona S; Department of Molecular Neuroscience, Institute of Neurology, University College London, London, UK.
  • Moazzeni H; School of Biology, College of Science, University of Tehran, Tehran, Iran.
  • Alavi A; Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
  • Heshmati A; School of Biology, College of Science, University of Tehran, Tehran, Iran.
  • Taghizadeh P; School of Biology, College of Science, University of Tehran, Tehran, Iran.
  • Nilipour Y; Pediatric Pathology Research Center, Research Institute for Children Health, Mofid and Shohaday-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Ghazanfari T; Simorg Pathobiology Laboratory, Tehran, Iran.
  • Shahabi M; Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran.
  • Okhovat AA; Department of Neurology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Rohani M; Department of Neurology, Hazrat Rasool Hospital, Iran University of Medical Sciences, Tehran, Iran.
  • Valle G; Department of Biology and CRIBI Biotechnology Centre, University of Padova, Padova, Italy.
  • Boostani R; Department of Neurology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Abdi S; Department of Neurology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Eshghi S; Department of Neurology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Nafissi S; Department of Neurology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran; Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: nafisi@sina.tums.ac.ir.
  • Elahi E; School of Biology, College of Science, University of Tehran, Tehran, Iran. Electronic address: elaheelahi@ut.ac.ir.
Neurobiol Aging ; 99: 102.e1-102.e10, 2021 03.
Article em En | MEDLINE | ID: mdl-33189404
ABSTRACT
Brown-Vialetto-Van Laere (BVVL) and Fazio-Londe are disorders with amyotrophic lateral sclerosis-like features, usually with recessive inheritance. We aimed to identify causative mutations in 10 probands. Neurological examinations, genetic analysis, audiometry, magnetic resonance imaging, biochemical and immunological testings, and/or muscle histopathology were performed. Mutations in known causative gene SLC52A3 were found in 7 probands. More importantly, only 1 mutated allele was observed in several patients, and variable expressivity and incomplete penetrance were clearly noted. Environmental insults may contribute to variable presentations. Putative causative mutations in other genes were identified in 3 probands. Two of the genes, WDFY4 and TNFSF13B, have immune-related functions. Inflammatory responses were implicated in the patient with the WDFY4 mutation. Malfunction of the immune system and mitochondrial anomalies were shown in the patient with the TNFSF13B mutation. Prevalence of heterozygous SLC52A3 BVVL causative mutations and notable variability in expressivity of homozygous and heterozygous genotypes are being reported for the first time. Identification of WDFY4 and TNFSF13B as candidate causative genes supports conjectures on involvement of the immune system in BVVL and amyotrophic lateral sclerosis.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Paralisia Bulbar Progressiva / Proteínas de Membrana Transportadoras / Peptídeos e Proteínas de Sinalização Intracelular / Fator Ativador de Células B / Estudos de Associação Genética / Mutação Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Neurobiol Aging Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Irã

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Paralisia Bulbar Progressiva / Proteínas de Membrana Transportadoras / Peptídeos e Proteínas de Sinalização Intracelular / Fator Ativador de Células B / Estudos de Associação Genética / Mutação Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Neurobiol Aging Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Irã